Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1998 1
2000 1
2007 2
2008 1
2009 1
2010 2
2011 1
2012 1
2013 2
2014 3
2015 5
2017 3
2018 3
2019 1
2021 2
2022 1
2023 3
2024 11
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 39288243

43 results

Results by year

Filters applied: . Clear all
Page 1
Evidence reviews for clinical features or factors that suggest treatment should be switched or stopped for people diagnosed with proliferative diabetic retinopathy or diabetic macular oedema: Diabetic retinopathy: Evidence review H.
[No authors listed] [No authors listed] London: National Institute for Health and Care Excellence (NICE); 2024 Aug. London: National Institute for Health and Care Excellence (NICE); 2024 Aug. PMID: 39288243 Free Books & Documents. Review.
Evidence reviews for effectiveness of different thresholds or criteria for starting treatment for non-proliferative diabetic retinopathy, proliferative diabetic retinopathy, and diabetic macular oedema: Diabetic retinopathy: management and monitoring: Evidence review B.
[No authors listed] [No authors listed] London: National Institute for Health and Care Excellence (NICE); 2024 Aug. London: National Institute for Health and Care Excellence (NICE); 2024 Aug. PMID: 39348478 Free Books & Documents. Review.
Evidence reviews for the effectiveness and acceptability of intravitreal steroids, macular laser and anti-vascular endothelial growth factor agents for treating diabetic macular oedema: Diabetic retinopathy: management and monitoring: Evidence review G.
[No authors listed] [No authors listed] London: National Institute for Health and Care Excellence (NICE); 2024 Aug. London: National Institute for Health and Care Excellence (NICE); 2024 Aug. PMID: 39312615 Free Books & Documents. Review.
Evidence reviews for the effectiveness and acceptability of anti-vascular endothelial growth factor agents and laser photocoagulation (alone or in combination) for the treatment of non-proliferative and proliferative diabetic retinopathy: Diabetic retinopathy: management and monitoring: Evidence review E.
[No authors listed] [No authors listed] London: National Institute for Health and Care Excellence (NICE); 2024 Aug. London: National Institute for Health and Care Excellence (NICE); 2024 Aug. PMID: 39348481 Free Books & Documents. Review.
Evidence review for effectiveness of treatments before, during or after cataract surgery for managing non-proliferative diabetic retinopathy, proliferative diabetic retinopathy or diabetic macular oedema: Diabetic retinopathy: Evidence review I.
[No authors listed] [No authors listed] London: National Institute for Health and Care Excellence (NICE); 2024 Aug. London: National Institute for Health and Care Excellence (NICE); 2024 Aug. PMID: 39288240 Free Books & Documents. Review.
Laser photocoagulation for proliferative diabetic retinopathy.
Evans JR, Michelessi M, Virgili G. Evans JR, et al. Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD011234. doi: 10.1002/14651858.CD011234.pub2. Cochrane Database Syst Rev. 2014. PMID: 25420029 Free PMC article. Review.
[Angiopathy and the eye].
Rencová E. Rencová E. Vnitr Lek. 2010 Apr;56(4):333-9. Vnitr Lek. 2010. PMID: 20465107 Review. Czech.
43 results